AI Scribes Are Spreading Through Clinics Faster Than the Rules Around Them

What happened

Australia's federal health department has raised concerns about doctors' use of AI scribes — tools that record, transcribe and summarise consultations into medical notes — while the country's health regulator weighs whether stronger safeguards are needed, the Guardian reported on 5 July. The scale of adoption explains the attention: a Royal Australian College of General Practitioners poll cited in the report found use among doctors nearly doubled from 22% in August 2024 to 40% in November 2025. Departmental briefing documents obtained under freedom of information laws noted the tools have little oversight, and that digital scribes are only regulated as medical devices if they serve a therapeutic purpose.

Why it matters

The appeal is real and should not be dismissed. Documentation consumes clinical hours, feeds burnout and pulls a doctor's eyes towards a keyboard rather than a patient. But a consultation is not ordinary workplace audio. It can contain mental health disclosures, sexual health, family history, finances and immigration worries — and turning that exchange into recorded data, cloud processing and a machine-generated summary changes the privacy profile of the appointment entirely. The regulatory distinction flagged by the department matters too: a tool that shapes the clinical record and the evidence trail for care can be practically consequential even when its formal category is uncertain.

There are two quieter risks. The first is thin consent — a hurried mention at the start of an appointment that patients feel unable to refuse is not informed agreement, especially when summaries can inherit the errors and false confidence of large language models. The second is financial: the department noted some suppliers advertised a possible 30% revenue increase for health professionals without extra hours or consultations, with implications for Medicare costs. That widens the story from privacy to incentives, and regulators will need to examine both.

The counter-view

None of this argues for rejection. Used well, AI scribes could reduce burnout, produce fuller notes and give patients a doctor who looks at them rather than a screen. The sensible model is unglamorous: AI drafts treated as drafts, clinicians accountable for the final record, plain-language explanations before recording starts, and the genuine ability to say no without care becoming grudging.

What happens next

The pattern to watch is sequencing. Clinics are adopting before national guidance is settled; vendors are making claims before standards are transparent; patients are meeting the technology before anyone has publicly explained its limits. Trust is carrying the weight that governance should. AI in healthcare will ultimately be judged not by the minutes it saves but by whether people still feel safe speaking honestly while it listens — and that depends on boundaries being drawn before habits harden, not after.